Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ClickSlim vs Kova

ClickSlim
Graded #490

Higher grade

vs+5.600000000000001
Kova
Graded #498

Lower grade

The verdict

ClickSlim takes it — 49.9/100 to 44.3/100.

ClickSlim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wyoming-registered telehealth selling compounded tirzepatide and NAD+ on introductory rates that step up after the first month, with no published state list.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueClickSlim +12
32
20
Dose & formulationClickSlim +12
52
40
Clinical oversightKova +11
60
71
Labs & monitoringEven
52
52
FulfillmentClickSlim +4
65
61
Contract termsClickSlim +24
49
25
ClickSlim · left barKova · right bar

The numbers

MetricClickSlimKova
WeighScore49.9/10044.3/100
GradeCC
Scorecard rank#490#498
SemaglutideNot disclosedNot disclosed
Tirzepatide$349/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
ClickSlim

Graded #490 · C

Strengths

  • Both the introductory and the ongoing price are published, so the step-up is visible before you buy
  • States plainly that it is not a pharmacy or a drug manufacturer and that medication is dispensed by a licensed third party
  • Text support line published with stated hours
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Its own NAD+ product card is labelled CONTAINS TIRZEPATIDE, which contradicts the product it is selling
  • No state list is published; the site says only that services are available in most States
  • Prices are among the highest in the category, at $349 ongoing for tirzepatide
  • Registered at a Sheridan, Wyoming suite address commonly used as a mail-forwarding and registered-agent address
  • Terms set arbitration in San Diego under California law while the company address is in Wyoming
Kova

Graded #498 · C

Strengths

  • Publishes the full price ladder for all three plan terms — intro month and renewal rate — directly in its FAQ
  • Medication is included in the plan price, with no separate pharmacy charge
  • States plainly that its compounded GLP-1s are 'not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality'
  • Companion app tracks weight, protein and side effects, with medication schedule reminders
  • You are not charged unless a provider approves treatment

Where it loses points

  • At $449 per 4 weeks, the standing 1-month plan is among the most expensive compounded GLP-1 options we track
  • The advertised $129 is the 6-month plan's intro month only — that plan then renews at $1,794 every 24 weeks
  • Billed every 4 weeks rather than monthly, which is 13 charges a year instead of 12
  • Never names which GLP-1 molecule is dispensed — only 'compounded, non-FDA-approved GLP-1 medications'
  • No pharmacy or prescribing medical group is named anywhere on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard